Volume 8, Issue 1 (2022)
IEM 2022, 8(1): 53-60 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Kaur P, Kaur J. Prevalence of Cryptococcaemia in HIV Infected Patients with CD4 Counts of ≤100 Cells/mm3-A Cross Sectional Study in a Tertiary Care Hospital. IEM 2022; 8 (1) :53-60
URL: http://iem.modares.ac.ir/article-4-53166-en.html
URL: http://iem.modares.ac.ir/article-4-53166-en.html
1- Department of Microbiology, SGRD institute of Medical Sciences and Research, Amritsar, India , drpavneetkaursood@gmail.com
2- Department of Microbiology, SGRD institute of Medical Sciences and Research, Amritsar, India.
2- Department of Microbiology, SGRD institute of Medical Sciences and Research, Amritsar, India.
Abstract: (982 Views)
Backgrounds: This study aimed to investigate the prevalence of cryptococcaemia in HIV infected patients with CD4 counts of ≤100 cells/mm3 in a tertiary care hospital.
Materials & Methods: The present cross sectional study was conducted at the Sri Guru Ram Das Institute of Health Sciences and Research, India, as a tertiary care hospital. All HIV infected patients with CD4 counts of ≤100 cells/mm3, referring to the hospital during May 2020 to May 2021 were enrolled in this study. Blood samples taken from patients were processed for wet mounting, negative staining with India ink, gram staining, fungal culture, and cryptococcal antigen (CrAg) lateral flow assay (LFA). Statistical analysis was done using SPSS software Version 20.0 (SPSS Inc. Chicago, IL, USA) by employing Chi-square and Fisher’s exact tests to compare categorical variables.
Findings: Out of 100 patients enrolled, 28 (28%) cases had CD4 counts below 50, while 72 (84.7%) patients had CD4 counts in the range of 51-100. Also, 55 patients (55%) received antiretroviral therapy (ART), and 45 (45%) cases were ART naïve. About 56% of patients had no opportunistic infections, and 37% had pulmonary tuberculosis. Three samples were positive in LFA, showing a prevalence of 3%, while only one of the culture samples was positive for Cryptococcus species. However, low CD4 count was found to be strongly correlated with positive serum cryptococcal antigenemia.
Conclusion: The present study reveals that cryptococcal antigenemia is a health problem, and that cryptococcal antigen screening and treatment policy recommended by WHO should be performed routinely for HIV patients registered in ART centres in the current setting, especially for those who are ART naïve and have CD4 counts of ≤100 cells/mm3.
Materials & Methods: The present cross sectional study was conducted at the Sri Guru Ram Das Institute of Health Sciences and Research, India, as a tertiary care hospital. All HIV infected patients with CD4 counts of ≤100 cells/mm3, referring to the hospital during May 2020 to May 2021 were enrolled in this study. Blood samples taken from patients were processed for wet mounting, negative staining with India ink, gram staining, fungal culture, and cryptococcal antigen (CrAg) lateral flow assay (LFA). Statistical analysis was done using SPSS software Version 20.0 (SPSS Inc. Chicago, IL, USA) by employing Chi-square and Fisher’s exact tests to compare categorical variables.
Findings: Out of 100 patients enrolled, 28 (28%) cases had CD4 counts below 50, while 72 (84.7%) patients had CD4 counts in the range of 51-100. Also, 55 patients (55%) received antiretroviral therapy (ART), and 45 (45%) cases were ART naïve. About 56% of patients had no opportunistic infections, and 37% had pulmonary tuberculosis. Three samples were positive in LFA, showing a prevalence of 3%, while only one of the culture samples was positive for Cryptococcus species. However, low CD4 count was found to be strongly correlated with positive serum cryptococcal antigenemia.
Conclusion: The present study reveals that cryptococcal antigenemia is a health problem, and that cryptococcal antigen screening and treatment policy recommended by WHO should be performed routinely for HIV patients registered in ART centres in the current setting, especially for those who are ART naïve and have CD4 counts of ≤100 cells/mm3.
Article Type: Original Research |
Subject:
Mycology
Received: 2021/06/9 | Accepted: 2021/11/12 | Published: 2022/02/21
Received: 2021/06/9 | Accepted: 2021/11/12 | Published: 2022/02/21
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |